Researchers at [b]Mayo Clinic[/b] have released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes. [s]News-Medical[/s] reports that the study found that the continuation of metformin after a cirrhosis diagnosis improved survival rates among diabetes patients. Metformin, used to treat high blood sugar levels caused by type 2 diabetes, is usually discontinued once cirrhosis is diagnosed, because of concerns about an increased risk of adverse effects associated. With the potential implications for a major change in current clinical practice, the researchers plan to collaborate with more institutions and use nationwide databases to further validate the beneficial effects of metformin.
[link url=http://www.news-medical.net/news/20140620/Continuation-of-metformin-after-cirrhosis-diagnosis-improves-survival-rates-in-diabetes-patients.aspx]Full News-Medical report[/link]
[link url=http://onlinelibrary.wiley.com/doi/10.1002/hep.27199/abstract]Hepatology abstract[/link]